Skip to Main Content

Author Details

Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
1992
80
31
PMIDPaper TitleJournal TitlePublished Year
36372724Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia.J Geriatr Oncol2023
37452070Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling.Cell Death Dis2023
37444542Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.Cancers (Basel)2023
37296594Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells.Cells2023
37066307Myelodysplastic syndromes disable human CD271+VCAM1+CD146+ niches supporting normal hematopoietic stem/progenitor cells.bioRxiv2023
36918531The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies.Bone Res2023
34839054A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.Leuk Res2022
36157246Dendritic cell-mimicking scaffolds for ex vivo T cell expansion.Bioact Mater2022
34949540Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2).J Geriatr Oncol2022
33040623Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.Leuk Lymphoma2021
33540474A large co-operative biological and clinical study to better understand and improve treatment of the rare t(8;16)(p11;p13) acute myeloid leukaemia.Br J Haematol2021
33580203Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia.Leukemia2021
33500244Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence.Cancer Discov2021
34525170Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes.Blood Adv2021
34218349Oral white lesion in patients post-hematopoietic stem cell transplantation: a case series demonstrating the diagnostic dilemma.Support Care Cancer2021
34138728Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy.Sci Adv2021
31492897Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.Leukemia2020
33884374Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells.Nat Cancer2020
31957517A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study.Leuk Lymphoma2020
33166406Decisional involvement and information preferences of patients with hematologic malignancies.Blood Adv2020
32822582Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.Cell Stem Cell2020
32961375Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.Biol Blood Marrow Transplant2020
32471661Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.Hum Immunol2020
30699367Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia.Transl Oncol2019
31698457Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells.Blood Adv2019
31779976What is the role of the microenvironment in MDS?Best Pract Res Clin Haematol2019
31036385Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes.Blood Rev2019
30943405The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells.Cell Rep2019
30915450Post-Transfusion Purpura Mimicking Idiopathic Thrombocytopenic Purpura: A Case Report.Lab Med2019
30911166FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels.Nat Nanotechnol2019
30998506Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B.JCI Insight2019
30279500The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.Sci Rep2018
27998707Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.Clin Lymphoma Myeloma Leuk2017
28280079Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.Haematologica2017
27322744Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia.Nat Med2016
26637787Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.Blood2016
27699999Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.Cancer Med2016
27421961Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.Blood2016
27473813Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse.Int J Radiat Oncol Biol Phys2016
26177509Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia.PLoS One2015
26628369A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species.Cell Rep2015
24577530Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.Leukemia2014
25003027Extracellular crystals in plasma cell myeloma.Leuk Res Rep2014
24870236The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.Nature2014
24934933Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia.Mol Cancer Ther2014
23085343Leukemia specific loss of heterozygosity of MHC in a CLL patient: disease state impacts timing of confirmatory typing.Hum Immunol2013
24120380A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.Biol Blood Marrow Transplant2013
24089526Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.J Biol Chem2013
24062389Defining patient-specific risk in acute myeloid leukemia.J Clin Oncol2013
24138944A phase I study of decitabine and rapamycin in relapsed/refractory AML.Leuk Res2013
  • 1 - 50 of 80

Recommended Authors

Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 1
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 0
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 4
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 5
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 4
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 2
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 6
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 2
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 7
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 7
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 5
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 7
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 3
Ravi Bhatia
University of Alabama at Birmingham
Career Start Year 1992
Number of shared co-authors 6
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 5
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 3
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 3
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year 1989
Number of shared co-authors 2
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 4
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 1
Marcela Gronda
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 1
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 0
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 8
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 9
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 5
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 5
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 3

Collaborators

Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 16
Shanshan Pei
Zhejiang University Medical Center
Co-authored papers 7
Mohammad Minhajuddin
University of Colorado School of Medicine
Co-authored papers 7
Gerald W Dorn
Co-authored papers 5
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 4
Haobin Ye
Institute of Metabolism & Integrative Biology, Fudan University
Co-authored papers 4
Ari Melnick
Co-authored papers 4
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 4
Francine E Garrett-Bakelman
University of Virginia
Co-authored papers 3
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Clayton A Smith
University of Colorado, Aurora CO.
Co-authored papers 3
Courtney L Jones
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Diana Abbott
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Co-authored papers 2
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Co-authored papers 2
Rachel Culp-Hill
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Anna Krug
University of Colorado School of Medicine
Co-authored papers 2
Donna Neuberg
Co-authored papers 2
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Kathleen E McGrath
Co-authored papers 2
Maura Gasparetto
University of Colorado School of Medicine
Co-authored papers 2
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 2
Maria Amaya
University of Colorado School of Medicine
Co-authored papers 1
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers 1
Areej El-Jawahri
Harvard Medical School
Co-authored papers 1
Ravindra Majeti
Stanford University School of Medicine
Co-authored papers 1
James DeGregori
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Sarah Gehrke
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Anna L Brown
Adelaide Medical School, University of Adelaide
Co-authored papers 1
Sheng Li
Co-authored papers 1
Zhu Chen
Yong Loo Lin School of Medicine, National University of Singapore
Co-authored papers 1
Release 1.2